Coding at birth: Nuffield Council on Bioethics publishes briefing note on whole genome sequencing of babies

March 27, 2018

The Nuffield Council on Bioethics has today published a briefing note that examines the ethical issues raised by whole genome sequencing of babies.

Whole genome sequencing is starting to be used in the NHS in the care of seriously ill babies, and could also become available to parents through commercial companies in future. The technology has the potential to reveal large amounts of genetic information about the baby, raising questions about how this information will be interpreted, shared with parents, stored and used by others.

Whole genome sequencing using a blood or saliva sample is now cheaper and faster than ever before. It usually takes around four weeks and costs around £1,000. However, interpreting the results remains difficult, time-consuming, and expensive.

Why sequence the genome of babies?

Whole genome sequencing can help to diagnose a seriously ill baby with a suspected genetic disease, or to predict how a baby will respond to medicines. It could also be used to predict a baby's chance of developing disease in childhood or adulthood, to find out about genetic factors that could affect future siblings, and to contribute to research databases to help better understand genetic disease. However, the significance of large amounts of the genetic code is currently unknown.

Whole genome sequencing is not yet widely available in the NHS, but that is likely to change with advances in genomic medicine, for example with the completion later this year of the UK's 100,000 Genomes Project. Some suggest that the NHS newborn screening programme should be expanded to include more childhood conditions, and that using whole genome sequencing could become a cost effective way to achieve this.

In the commercial sector, whole genome sequencing is already available to adults through several US companies. Some companies offer or are planning to offer newborn screening tests that search for large numbers of genetic conditions.

Ethical issues

Whole genome sequencing of babies raises important questions about what kind of genetic information should be shared with parents, how parents can be supported to make informed choices, and how genomic information should be stored and accessed by others, such as researchers. There are also broader questions about whether increased uptake of whole genome sequencing will change views about genetic variation and disability in society.

The briefing note concludes that: Professor Dave Archard, Chair of the Nuffield Council on Bioethics says:

"Genome sequencing technology has moved at an incredible pace, and we are starting to see the benefits that it can offer to patients with genetic disease. But we need to think carefully about how we handle the sensitive information that can be revealed. Babies do not get a say in this, making it especially important that they, and others, are not disadvantaged in their future lives by a decision taken at birth. We need to make sure there are opportunities for public consideration of the challenges."
-end-
Notes to editors

The Nuffield Council on Bioethics is an independent body that has been advising policy makers on ethical issues in bioscience and medicine for more than 25 years. As well as being a key UK partner on international networks of advisory bodies, the Council has an international reputation for advising policy-makers and stimulating debate in bioethics. The Council is funded by the Nuffield Foundation, the Medical Research Council, and Wellcome.

This is the second in a new series of bioethics briefing notes published by the Council. The first focused on 'The search for a treatment for ageing'. We will publish further bioethics briefing notes this year on topics including the use of artificial intelligence in healthcare, and identification biometrics.

Nuffield Council on Bioethics

Related Genome Articles from Brightsurf:

Genome evolution goes digital
Dr. Alan Herbert from InsideOutBio describes ground-breaking research in a paper published online by Royal Society Open Science.

Breakthrough in genome visualization
Kadir Dede and Dr. Enno Ohlebusch at Ulm University in Germany have devised a method for constructing pan-genome subgraphs at different granularities without having to wait hours and days on end for the software to process the entire genome.

Sturgeon genome sequenced
Sturgeons lived on earth already 300 million years ago and yet their external appearance seems to have undergone very little change.

A sea monster's genome
The giant squid is an elusive giant, but its secrets are about to be revealed.

Deciphering the walnut genome
New research could provide a major boost to the state's growing $1.6 billion walnut industry by making it easier to breed walnut trees better equipped to combat the soil-borne pathogens that now plague many of California's 4,800 growers.

Illuminating the genome
Development of a new molecular visualisation method, RNA-guided endonuclease -- in situ labelling (RGEN-ISL) for the CRISPR/Cas9-mediated labelling of genomic sequences in nuclei and chromosomes.

A genome under influence
References form the basis of our comprehension of the world: they enable us to measure the height of our children or the efficiency of a drug.

How a virus destabilizes the genome
New insights into how Kaposi's sarcoma-associated herpesvirus (KSHV) induces genome instability and promotes cell proliferation could lead to the development of novel antiviral therapies for KSHV-associated cancers, according to a study published Sept.

Better genome editing
Reich Group researchers develop a more efficient and precise method of in-cell genome editing.

Unlocking the genome
A team led by Prof. Stein Aerts (VIB-KU Leuven) uncovers how access to relevant DNA regions is orchestrated in epithelial cells.

Read More: Genome News and Genome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.